Patent · US Active

Probiotic bifidobacterium strain

US10144978B2 · kind B2 · utility

4Cited by
1References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 10, 2012
Grant dateDec 4, 2018
Priority date—
Expiry dateAug 18, 2033

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Probiotic Bifidobacterium strain AH1714 is significantly immunomodulatory following oral consumption. The strain is useful as an immunomodulatory biotherapeutic agent.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.